Pulmonary and pleura damage in the process cardiosurgical intervention: etiology, pathogenesis, prevention (Review)
摘要
Pulmonary and pleura damage are one of the most common postoperative complications. The prevalence of pulmonary dysfunction following cardiac surgery is 76%. The risk factors are: preoperative respiratory disease, body mass index over 30 kg/m2, intraoperational heart ice encasing, duration of cardiopulmonary bypass period. From a heart surgeon and pathophysiologist prospective, the paper discusses the mechanisms of lung tissue destruction and patient preparation to reduce the incidence and/severity of complications. The data analysis suggests that this factors should be accounted for when planning the operation to reduce the risk of life-threatening complications.
关于作者
Yu. Belov
Federal State Scientific Institution Petrovsky Russian Scientific Center of Surgery
俄罗斯联邦
俄罗斯联邦
P. Litvitsky
I.M. Sechenov First MSMU (Sechenov University)
俄罗斯联邦
俄罗斯联邦
I. Vinokurov
I.M. Sechenov First MSMU (Sechenov University)
俄罗斯联邦
俄罗斯联邦
参考
1. Бабринская И.Г., Уклонский А.Н. Дыхательная недостаточность послеоперационного периода у торакальных больных. Вестник Кыргызско-Российского славянского университета. 2014; 5: 35-38
2. Ferguson M.K. Preoperative assessment of pulmonary risk. Chest. 1999; 115(5 Suppl): 58S-63S
3. Trouillet J.L., Luyt C.E., Guiguet M. et al. Earlypercutaneous tracheotomy versus prolonged intubation of mechanically ventilated patients after cardiac surgery: a randomized trial. Ann. Intern. Med. 2011; Mar 15; 154(6): 373-383
4. Cordeiro A.L., Melo T.A., Neves D. et al. Inspiratory muscle training and functional capacity in patients undergoing cardiac surgery. Cardiovasc. Surg. 2016; Apr; 31(2): 140-144
5. Freitas E.R., Soares B., Cardoso J.R., Atallah Á.N. Incentive spirometry for preventing pulmonary complications after coronary artery bypass graft (Review). The Cochrane Library. 2009; Iss. 1
6. Felcar J.M., Guitti J.C., Marson A.C., Cardoso J.R. Preoperative physiotherapy in prevention of pulmonary complications in pediatric cardiac surgery. Rev. Bras. Cir. Cardiovasc. 2008; 23(3): 383-388
7. Yamashiro S., Kuniyoshi Y., Arakaki K., Inafuku H., Morishima Y., Kise Y. Aortic replacement via median sternotomy with left anterolateral thoracotomy. Asian Cardiovasc. Thorac. Ann. 2009; 17: 373-377
8. Mehran R.J., Martin L.W., Baker C.M. et al. Pain management in an enhanced recovery pathway after thoracic surgical procedures. Ann. Thorac. Surg. 2016; Dec; 102(6): e595-e596
9. Muehling B.M., Halter G.L., Schelzig H., Meierhenrich R., Steffen P., Sunder-Plassmann L., Orend K. Reduction of postoperative pulmonary complications after lung surgery using a fast track clinical pathway. Eur. J. of Cardio-thoracic Surg. 2008; 34: 174-180
10. Rudra A., Das S. Postoperative pulmonary complications. Indian J. of anaesthesia. 2006; 50(2): 89-98
11. Suemitsu R., Sakoguchi T., Morikawa K., Yamaguchi M., Tanaka H., Takeo S. Effect of body mass index on perioperative complications in thoracic surgery. Asian Cardiovasc. Thorac. Ann. 2008; 16: 463-467
12. Авдеев С.Н. Плевральные выпоты в интенсивной терапии. Consilium Medicum. Приложение «Пульмонология». 2009; 1: 21-26
13. Merino-Ramirez M.A., Juan G., Ramón M. et al. Electrophysiologic evaluation of phrenic nerve and diaphragm function after coronary bypass surgery: prospective study of diabetes and other risk factors. J. Thorac. Cardiovasc. Surg. 2006; Sep; 132(3): 530-536, 536.e1-2
14. Гасанов А.Ф. Легочно-плевральные осложнения в хирургии нисходящего отдела грудной аорты. Автореферат … канд. мед. наук. М.; 2012: 24
15. Westerdahl E., Jonsson M., Emtner M. Pulmonary function and health-related quality of life 1-year follow up after cardiac surgery. J. Cardiothorac. Surg. 2016; Jul 8; 11(1): 99
16. Savas O.Z.B., Kaya E., Arslan G. et al. Pre-treatment before coronary artery bypass surgery improves post-outcomes in moderate chronic obstruction pulmonary disease patients. Cardiovasc. J. of Africa. 2013; 24(5): 184-187
17. Apostolakis E., Filos K., Koletsis E., Dougenis D. Lung dysfunction following cardiopulmonary bypass. J. Card. Surg. 2010; 25(1): 47-55
18. Massoudy P., Zahler S., Becker B.F., Braun S.L., Barankay A., Meisner H. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass. Chest. 2001; 119: 31-36
19. Roth-Isigkeit A., Hasselbach L., Ocklitz E. et al. Inter-individual differences in cytokine release in patients undergoing cardiac surgery with cardiopulmonary bypass. Clin. Exp. Immunol. 2001; 125: 80-88. Conti V.R. Pulmonary injury after cardiopulmonary bypass. Chest. 2001; 119: 2-4
20. Gu Y.J., de Vries A.J., Vos P., Boonstra P.W., van Oeveren W. Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit. Ann. Thorac. Surg. 1999; 67: 604-609
21. Goldman M., Webert K.E., Arnold D.M., Freedman J., Hannon J., Blajchman M.A. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus. Med. Rev. 2005; 19(1): 2-31
22. Stainsby D., Jones H., Asher D. et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus. Med. Rev. 2006; 20(4): 273-282
23. Bux J., Sachs U.J. The pathogenesis of transfusion-related acute lung injury (TRALI). Br. J. Haematol. 2007; 136(6): 788-799
24. Vlaar A.P., Porcelijn L., Van Rooijen Schreurs I., Lardy N.M., Kersten M.J., Juffermans N.P. The divergent clinical presentations of transfusion-related acute lung injury illustrated by two case reports. Med. Sci. Monit. 2010; 16(10): CS129-CS134
25. Kumar R., Sedky M.J., Varghese S.J. et al. Transfusion related acute lung injury (TRALI): A single institution experience of 15 years. Indian J. Hematol. Blood Transfus. 2016; Sep; 32(3): 320-327
26. Asimakopoulos G., Smith P.L.C., Ratnatunga C.P., Taylor K.M. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann. Thorac. Surg. 1999; 68: 1107-1115
27. Lohser J., Slinger P. Lung injury after one-lung ventilation: A review of the pathophysiologic mechanisms affecting the ventilated and the collapsed lung. Anesth. Analg. 2015; Aug; 121(2): 302-318
28. Akbariasbagh P., Mirzaghayan M.R., Akbariasbagh N. et al. Risk ractors for post-cardiac surgery diaphragmatic paralysis in children with congenital heart disease. J. Tehran. Heart. Cent. 2015; Jul 3; 10(3): 134-139
29. Bougioukas I., Didilis V., Emigholz J. et al. The effect of amifostine on lung ischaemia-reperfusion injury in rats. Interact. Cardiovasc. Thorac. Surg. 2016; Aug; 23(2): 273-279
30. Matata B., Galinanes M. Peroxynitrite is an essential component of cytokines production mechanism in human monocytes through modulation of nuclear factor-kappa B DNA binding activity. J. Biol. Chem. 2002; 277: 2330-2335
31. Perrot M., Liu M., Waddell T., Keshavjee S. Ischemia-reperfusion-induced lung injury. Am. J. Respir. Crit. Care. Med. 2003; 167: 490-511
32. Fisher A.B. Reactive oxygen species and cell signaling with lung ischemia. Undersea Hyperb. Med. 2004; Spring; 31(1): 97-103
33. Colombat M., Castier Y., Leseche G., Rufat P., Mal H., Thabut G. et al. Early expression of adhesion molecules after lung transplantation: evidence for a role of aggregated P-selectin-positive platelets in human primary graft failure. J. Heart. Lung. Transplant. 2004; 23(9): 1087-1092
34. Cadenas E. Mitochondrial free radical production and cell signaling. Mol. Aspects. Med. 2004; 25(1-2): 17-26
35. Kadenbach B. Intrinsic and extrinsic uncoupling of oxidative phosphorylation. Biochim. Biophys. Acta. 2003; Jun 5; 1604(2): 77-94
36. Landmesser U., Dikalov S., Price S.R., McCann L., Fukai T., Holland S.M., Mitch W.E., Harrison D.G. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 2003; 111(8): 1201-1209
37. Esme H., Fidan H., Koken T., Solak O. Effect of lung ischemia-reperfusion on oxidative stress parameters of remote tissues. Eur. J. Cardiothorac. Surg. 2006; 29(3): 294-298
38. Murphy M.P., Holmgren A., Larsson N.G., Halliwell B., Chang C.J., Kalyanaraman B. et al. Unraveling the biological roles of reactive oxygen species. Cell. Metab. 2011; 13: 361-366
39. Du S., Ai J., Zeng X., Wan J. et al. Plasma level of advanced oxidation protein products as a novel biomarker of acute lung injury followingcardiac surgery. Springerplus. 2016; Feb 29; 5: 231
40. Gothard J. Lung injury after thoracic surgery and one-lung ventilation. Curr. Opin. Anaesthesiol. 2006; 19(1): 5-10
41. Zhang X., Gao F., Yan Y. et al. Combination therapy with human umbilical cord mesenchymal stem cells and angiotensin-converting enzyme 2 is superior for the treatment of acute lung ischemia-reperfusion injury in rats. Cell Biochem. Funct. 2015; Apr; 33(3): 113-120
42. Den Hengst W., Gielis J., Lin J., Van Schil P., De Windt L., Moens A. Lung ischaemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am. J. Physiol. Circ. Physiol. 2010; 299: H1283-1299
43. Bougioukas I., Didilis V., Emigholz J. et al. The effect of amifostine on lung ischaemia-reperfusion injury in rats. Interact. Cardiovasc. Thorac. Surg. 2016; Aug; 23(2): 273-279
44. Roberts A.M., Ovechkin A.V., Mowbray J.G., Robinson T.W., Lominadze D. Effects of pulmonary ischemia-reperfusion on platelet adhesion in subpleural arterioles in rabbits. Microvasc. Res. 2004; 67(1): 29-37
评论
浏览:
723
Email this article 